Assembly Biosciences Non Operating Income Net Other Over Time

ASMB Stock  USD 27.00  0.78  2.97%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Assembly Biosciences Performance and Assembly Biosciences Correlation.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.The current year's Non Operating Income Net Other is expected to grow to about 1.3 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(4.60)
Revenue Per Share
4.319
Quarterly Revenue Growth
0.576
Return On Assets
(0.16)
Return On Equity
(0.37)
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Non Operating Income Net Other Analysis

Compare Assembly Biosciences and related stocks such as Zura Bio Limited, Foghorn Therapeutics, and Immuneering Corp Non Operating Income Net Other Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
FHTX710 K710 K710 K710 K710 K710 K710 K710 K710 K710 K710 K1.3 M8.3 M8.3 M8.3 M9.5 M10 M
IMRX(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)(6.2 K)1.3 M1.3 M1.3 M1.4 M1.5 M
ENTA629 K629 K629 K301 K1.3 M1.8 M2.4 M(59 K)149 K149 K(27 K)83 K83 K83 K83 K74.7 K71 K
NAUT183 K183 K183 K183 K183 K183 K183 K183 K183 K183 K183 K183 K(122 K)(122 K)(122 K)(109.8 K)(104.3 K)
ARCT(478 K)(478 K)(478 K)(478 K)(478 K)(478 K)(478 K)(478 K)(478 K)(478 K)(624 K)(822 K)(822 K)(822 K)(822 K)(739.8 K)(776.8 K)
PYXS(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)(6.3 M)2.8 M2.8 M2.8 M3.2 M3.3 M
TNYA85 K85 K85 K85 K85 K85 K85 K85 K85 K85 K85 K85 KMMM2.2 M2.4 M

Assembly Biosciences and related stocks such as Zura Bio Limited, Foghorn Therapeutics, and Immuneering Corp Non Operating Income Net Other description

My Equities

My Current Equities and Potential Positions

Assembly Biosciences
ASMB
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Business AddressTwo Tower Place,
ExchangeNASDAQ Exchange
USD 27.0
When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:
Check out Assembly Biosciences Performance and Assembly Biosciences Correlation.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Assembly Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Assembly Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Assembly Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...